Neuraxis Inc. (NRXS)
NYSE · Healthcare
Neuraxis Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 3.6M | 2.7M | 2.5M | 2.7M |
| Gross Profit | 3.0M | 2.3M | 2.2M | 2.4M |
| Profitability | ||||
| Operating Income | -7.8M | -7.2M | -6.7M | -3.4M |
| EBITDA | -7.8M | -7.1M | -6.6M | -3.3M |
| Net Income | -7.8M | -8.2M | -14.6M | -4.8M |
| Per Share Data | ||||
| EPS (diluted) | $-0.95 | $-1.22 | $-4.50 | $-2.77 |
| Shares Outstanding (dil.) | 9M | 7M | 3M | 2M |
Neuraxis Inc. Income Statement — FAQ
Neuraxis Inc. (NRXS) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRXS's income statement history?
The chart and table above show Neuraxis Inc.'s income statement by year and by quarter, including the growth rate.